The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
FIERCE-22: Clinical activity of vofatamab (V) a FGFR3 selective inhibitor in combination with pembrolizumab (P) in WT metastatic urothelial carcinoma, preliminary analysis.
 
Arlene O. Siefker-Radtke
Consulting or Advisory Role - AstraZeneca; Bavarian Nordic; BioClin Therapeutics; Bristol-Myers Squibb; EMD Serono; Genentech; Inovio Pharmaceuticals; Janssen; Lilly; Merck; NCCN; Nektar; Seagen
Research Funding - BioClin Therapeutics; Bristol-Myers Squibb; Janssen; Michael and Sherry Sutton Fund for Urothelial Cancer; Nektar; NIH; Takeda
Patents, Royalties, Other Intellectual Property - Methods of characterizing and treating molecular subsets of muscle-invasive bladder cancer.
 
Graeme Currie
Employment - Dynavax Technologies; Rainier Therapeutics
Leadership - Rainier Therapeutics
Stock and Other Ownership Interests - Dynavax Technologies; Gilead Sciences; Rainier Therapeutics; Regeneron
Consulting or Advisory Role - Bolt Biotherapeutics; NaNotics
 
Esteban Abella
Employment - Rainier Therapeutics
Leadership - Rainier Therapeutics
Stock and Other Ownership Interests - Rainier Therapeutics
 
Daniel A. Vaena
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Exelixis
Research Funding - Aeglea Biotherapeutics (Inst); AstraZeneca (Inst); BioClin Therapeutics (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Compugen (Inst); Merck (Inst); Nektar (Inst); Novartis (Inst); Peloton Therapeutics (Inst); TG Therapeutics (Inst); Tizona Therapeutics, Inc. (Inst)
Travel, Accommodations, Expenses - Caris Centers of Excellence; Genomic Health
 
Arash Rezazadeh Kalebasty
No Relationships to Disclose
 
Giuseppe Curigliano
Honoraria - Ellipses Pharma
Consulting or Advisory Role - Bristol-Myers Squibb; Foundation Medicine; Lilly; Novartis; Pfizer; Roche/Genentech; Samsung
Speakers' Bureau - Foundation Medicine; Lilly; Novartis; Pfizer; Roche/Genentech; Samsung
Travel, Accommodations, Expenses - Pfizer; Roche/Genentech
 
Krzysztof Tupikowski
No Relationships to Disclose
 
Zoran Gojko Andric
No Relationships to Disclose
 
Iwona Lugowska
No Relationships to Disclose
 
William Kevin Kelly
Honoraria - Constellation Pharmaceuticals; Janssen Oncology
Consulting or Advisory Role - Foundation Medicine; Sanofi
Research Funding - Bayer (Inst); Endocyte (Inst); Exelixis (Inst); Janssen Oncology (Inst); Novartis (Inst); Sanofi (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Janssen Oncology